![]() | ![]() |
Formats:
|
||||||||||||||||||||||||||
Copyright © 2008 by The National Academy of Sciences of the USA Biochemistry Probabilistic assembly of human protein interaction networks from label-free quantitative proteomics *Stowers Institute for Medical Research, Kansas City, MO 64110; and †Department of Biochemistry and Molecular Biology, Kansas University Medical Center, Kansas City, KS 66160 ‡To whom correspondence should be addressed. E-mail: mpw/at/stowers-institute.org Edited by Roger D. Kornberg, Stanford University School of Medicine, Stanford, CA, and approved December 7, 2007 Author contributions: M.E.S., L.F., and M.P.W. designed research; M.E.S., Y.C., J.J., and S.K.S. performed research; M.E.S., Y.C., and J.J. contributed new reagents/analytic tools; M.E.S., Y.C., J.J., S.K.S., R.C.C., J.W.C., L.F., and M.P.W. analyzed data; and M.E.S., R.C.C., J.W.C., L.F., and M.P.W. wrote the paper. Received July 25, 2007. Freely available online through the PNAS open access option. This article has been cited by other articles in PMC.Abstract Large-scale affinity purification and mass spectrometry studies have played important roles in the assembly and analysis of comprehensive protein interaction networks for lower eukaryotes. However, the development of such networks for human proteins has been slowed by the high cost and significant technical challenges associated with systematic studies of protein interactions. To address this challenge, we have developed a method for building local and focused networks. This approach couples vector algebra and statistical methods with normalized spectral counting (NSAF) derived from the analysis of affinity purifications via chromatography-based proteomics. After mathematical removal of contaminant proteins, the core components of multiprotein complexes are determined by singular value decomposition analysis and clustering. The probability of interactions within and between complexes is computed solely based upon NSAFs using Bayes' approach. To demonstrate the application of this method to small-scale datasets, we analyzed an expanded human TIP49a and TIP49b dataset. This dataset contained proteins affinity-purified with 27 different epitope-tagged components of the chromatin remodeling SRCAP, hINO80, and TRRAP/TIP60 complexes, and the nutrient sensing complex Uri/Prefoldin. Within a core network of 65 unique proteins, we captured all known components of these complexes and novel protein associations, especially in the Uri/Prefoldin complex. Finally, we constructed a probabilistic human interaction network composed of 557 protein pairs. Keywords: chromatin remodeling, normalized spectral abundance factor, multidimensional protein identification technology The assembly of protein interaction networks provides critical insight into the interrelationships of multiprotein complexes and the interconnections of their respective functions. To date, the study of protein interaction networks has largely been derived from yeast two-hybrid analyses in model organisms (1, 2) and higher eukaryotes (3, 4) and from large-scale affinity purification and mass spectrometry (APMS) analyses in the model organisms Saccharomyces cerevisiae (5, 6) and in humans (7). Although all of these approaches and datasets have proven to be highly valuable sources of information, the large-scale APMS analyses in yeast and humans were designed to determine the confidence of protein complex membership (5–7). Binary interactions, based on the presence and absence of proteins in purifications, are typically reported (8). In particular in yeast, the mathematical approaches for assembling protein complexes relies on very large-scale datasets (9) and on the reciprocity of bait and prey interactions where as many preys as possible are also baits (5, 6). Collins et al. (9) reported that applying such methods to a relatively small dataset resulted in less successful identification of protein–protein interactions. This raises the question of whether a human protein interaction network can be assembled from focused studies if a systematic dataset, which would require thousands of costly APMS experiments to generate, is not available. To address this challenge, we have developed a method for building probabilistic local networks that will allow focused studies of smaller-scale networks. The mammalian TIP49a (Rvb1) and TIP49b (Rvb2) proteins (hereafter refer to as TIP49a/b) belong to an evolutionary conserved family of AAA+ ATPases and are involved in multiple protein complexes. In S. cerevisiae, TIP49a/b are subunits of two distinct ATP-dependent chromatin remodeling complexes SWR1 (10, 11) and INO80 (12, 13). Protein complexes that share components are difficult to be computationally separated and analyzed. The complexity of such analysis was shown in yeast, where, for instance, the portion of the protein interaction network that includes the SWR1, INO80, and NuA4 complexes was grouped as one large module by using the Markov Clustering procedure (14), a key mathematical component used for the large-scale yeast APMS studies (5). In humans, TIP49a/b are components of at least four multiprotein complexes that play roles in chromatin remodeling [SRCAP (15), hINO80 (16), TRRAP/TIP60 (17), or nutrient sensing (Uri/Prefoldin (18)]. The complexity of the TIP49a/b local network in humans presents the analytical challenge of distinguishing these complexes from one another. Previous protein interaction network analyses have not taken advantage of quantitative shotgun proteomics technologies like spectral counting. The total number of peptides identifying a protein correlates strongly with the abundance of the protein (19–22). We have shown that the relative abundance of proteins can be estimated by using normalized spectral abundance factors (NSAFs) (23, 24), which are calculated from the total number of spectra identified for each protein, normalized to the protein's length and the total number of identified spectra for all proteins in the sample. Here, we show that NSAFs provide a foundation for a systematic approach to remove nonspecific interactions, define core complexes, and build a probabilistic protein interaction network. Results A High-Quality Dataset of Human TIP49a/b-Associated Proteins. A total of 27 different proteins were FLAG-tagged (hereafter referred to as “baits”), expressed in and purified by affinity purification from human tissue culture cells and analyzed by MudPIT [supporting information (SI) Fig. 5], leading to the identification of 1,278 nonredundant (NR) proteins (SI Table 1 A and B). Parallel analyses of 35 negative controls (extracts from untransformed parental cells passed through Flag affinity purification and analyzed by MudPIT) identified 812 NR proteins (SI Table 2 A and B). A crucial step in analyzing proteomics data is unraveling the subset of specific proteins from the nonspecific binders, i.e., contaminant proteins. To do so, we represented each detected protein (hereafter referred to as “prey”) as two vectors consisting of the NSAF values for each of the specific and the negative purifications, respectively. We calculated the vector ratio magnitude between the two sets (α) as a way to extract contaminants. A protein was considered a contaminant if α was >1, suggesting the protein was more abundant in the negative controls than in the specific experiments. After purging, the remaining 945 proteins were used for further analysis. Next, we constructed a matrix A (27 × 945), with the matrix element Aij representing the normalized spectral count, i.e., NSAF, for prey i and bait j, and applied singular value decomposition (SVD) (25) to extract the proteins enriched from the immunoprecipitations by using a rank estimated method. The resulting 125 proteins (SI Table 1C) included all previously reported members of the SRCAP (15), hINO80 (16), and TRRAP/TIP60 (17) multiprotein complexes and were subsequently used to determine the core complexes. Determination of Protein Complexes. We first focused our analysis on a cluster procedure based on reciprocal pull-down of bait pairs. This resulted in five main groups corresponding to (i) baits for which there was no or little reciprocal pull-down with other purifications, (ii) hINO80, (iii) Uri/prefoldin, (iv) SRCAP/TRRAP/TIP60 complexes, and (v) a cluster containing TIP49a and TIP49b, which also belong to groups 2, 3, and 4 (Fig. 1
Next, we predicted that all prey proteins overlapping between the baits within the same group and lying above a threshold form the actual complexes, where a prey protein had to appear in at least half of the baits used to define a given complex. The prey proteins that belonged to a single complex and were not shared by the other complexes are defined as the core components of the corresponding complex. Overall, the results obtained through this approach were consistent with reports from the literature (15–17). In addition to already-known components of the Uri/Prefoldin complex (18), we identified six additional subunits: HKE2, BC014022, POL3A, PDRG, FLJ21908, and FLJ20643. H2AZ was also assigned as a bona fide component of the SRCAP complex (15). Several prey proteins in the dataset were part of more than one complex and were defined as modules (Fig. 2 In the analysis of protein complexes, a clear distinction is sometimes made between core components and modules or attachments (6). Core components are normally stably associated with the complex and are experimentally recovered in reproducible stoichiometric yields. In contrast, modules and attachments, which may modulate the activity of the core complex, are often loosely or transiently associated with a specific protein or module and recovered in substoichiometric yields (27, 28). To assess these features, we performed hierarchical clustering analyses on the 27 immunoaffinity purifications (Fig. 3
Probabilistic Network Analysis with the Bayes Classifier. During the partitioning of the proteins into complexes, 10 other proteins consistently copurified with only a subset of baits in a complex. Because these proteins were not contaminants, they could either be essential for the synthesis/folding/stability/function of one or more components of the four major complexes or, alternatively, could represent a physical association outside these complexes. For instance, both human TIP49a/b and NOP5/NOP58 are known to interact with U14 snoRNA (29). Likewise, SRCAP is capable of remodeling chromatin by catalyzing the incorporation of H2AZ/H2B dimers into nucleosomes, perhaps explaining the specific presence of H2B in the purifications. Therefore, these 10 proteins, along with the 43 deemed core components of the complexes (Fig. 2 Although binary representation of APMS data has been successfully used to predict protein complexes and protein interactions, quantitative information based on NSAF could be a useful alternative to ascertain these predictions. Therefore, we used a probabilistic model for a protein interaction network that provides quantitative information for each interaction. In this model, each pair of proteins (bait–prey) received a probability computed only from the observed experimental NSAF values by using a Bayesian approach. For a bait–prey pair, the resulting probability quantifies the preference of the prey to associate with the bait. As suggested (30, 31), we used these probabilities to construct a probabilistic network of human TIP49a/b-containing complexes. To visualize our complexes, probabilistic networks were displayed in Fig. 4
Validation of Predicted Interactions. In vivo coimmunoprecipitation assays were conducted to test several interactions within the TRRAP/TIP60 complex (SI Fig. 6). This orthogonal analysis confirmed the interactions between MRGBP and TRCp120, DMAP, MRG15, TIP60, and YL1 (SI Fig. 6 A–E), which were all predicted with medium to high probabilities in our analysis (SI Table 4). The distinct interaction between SIT49ab (FLJ21945) and TIP49a/b was also confirmed in two separate experiments (SI Fig. 6 F–G). In addition, we systematically analyzed the human protein reference database (33) for additional confirmations of high-probability protein associations (SI Text). For instance, our analysis predicted strong association between YL-1 and H2AZ, which is supported by the demonstrated interaction between the S. cerevisiae orthologs of YL-1 (Swc2) and H2AZ (Htz1) (34). In TRRAP/TIP60, MRGBP has the highest probability of interaction with MRGX followed by MRG15–1, and these probabilities were the eighth and ninth highest in the entire dataset. Cai et al. (35) have shown that MRGBP-MRGX heterodimers, MRGBP-MRG15 heterodimers and MRGBP-MRG15-MRGX heterotrimers can be resolved by analytical superpose 6 gel filtration of a FLAG-MRGBP eluate. Discussion In this study, we have demonstrated the value of quantitative proteomics for organizing proteins into complexes and for generating probabilistic interaction networks. To begin, NSAF values are valuable for the extraction of contaminants. Many proteins known to be part of complexes can also be found in negative control purifications. By comparing the level of protein abundance between samples and an equal number of negative control purifications, we are able to separate those proteins that are quantitatively enriched in the samples over the negative controls. Indeed, all known components of each of the complexes were faithfully recovered among the putative true positive sets. Other large-scale studies, which did not use negative control runs, removed only those proteins that appear in more than a certain percentage of the purifications (5, 6, 36). If we were to take this approach with the current dataset, we would have to remove TIP49a and TIP49b from the datasets, even though these proteins are the foundation of this network. We devised a strategy that uses normalized spectral counts to generate a probabilistic measure of the preference of proteins to interact with one another. The probability between two proteins is calculated from the bait-to-prey relationship alone, whereas other methods require reciprocal bait–prey interactions or copurification of preys by a third bait (5, 6). By using this approach, we assigned probabilities not only to the interactions inside the complexes but also to the interactions outside the complexes. For instance, for SIT49a/b, which is not part of the four complexes, we were able to assign a high probability to TIP49a/b that was experimentally verified. The same holds true for FLJ20436, which forms an external interaction with the MCRS1 component of hINO80 complex. Thus far, there is no precise way to predict direct interaction based on APMS data. Nonetheless, there is a possibility that some pairs with high probability could form a direct contact. This information is particularly important when designing focused experimentation to disrupt particular interactions within a network. For example, the highest-probability pairs predicted for subunits of hINO80 were IES2/YY1 and IES2/FLJ20309 (Fig. 4 Materials and Methods Identification of Proteins by MudPIT. The cloning, expression, and purification of the human TIP49a, TIP49b, Arp8, PAPA-1 (hIES2), C18orf37 (hIes6), TCF3-Amida, and FLJ90652 full-length proteins and a fragment of FLJ20309 (residues 106–544) were reported by Jin et al. (16). N-terminally FLAG-tagged human MRGBP, YL-1, ZnF/HIT1, and H2AZ were obtained as described by Cai et al. (17). SCRAP-associated proteins were purified as described by Ruhl et al. (15). Full-length cDNAs encoding the human ZnF/HIT2, ARP5, ARP6, PDRG, UXT1, BC014022, FLJ20643, FLJ20436, FLJ21908, NUFIP, LIN9, FLJ20729, and DPCD proteins were obtained from the American Type Culture Collection (ATCC), subcloned with FLAG tags into pcDNA5/FRT, and introduced into HEK293/FRT cells by using the Invitrogen Flp-in system as reported (17). Next, TIP49a- and TIP49b-associating proteins were purified by anti-FLAG agarose immunoaffinity chromatography as described by Jin et al. (16). As a control for the specificity of immunoaffinity purifications, extracts prepared from untransformed parental cells (23 independent preparations from HeLa and 12 from HEK/293 cells) were subjected to the same procedure (SI Fig. 5). Identification of proteins was accomplished by Multidimensional Protein Identification Technology (MudPIT) as described (38), and details are provided in SI Text. Protein spectral counts were converted to the NSAF for subsequent analysis (SI Text). Contaminant Extraction. In this study, we define contaminants as follows: for M purifications and N identified proteins, let xij be the NSAF value of ith identified protein and jth purification. The vector [xi1 xi2… xiM] represents the protein vector with 1 ≤ i ≤ N, and 1 ≤ j ≤ M. Similarly, let yij represent the NSAF value of ith identified protein in the negative controls and jth control purification. The vector [yi1 yi2… yiM] represent the negative control protein vector. For each protein with two vectors x and y, the vector magnitude (α) is calculated as:
SVD. SVD is an established method (25, 39–41), and a mathematical definition is provided in SI Text. Here, we used SVD to find a group of proteins in the dataset that contributes most to the matrix by using a ranking estimation method. SVD analysis revealed that the first singular value and associated singular vectors contribute the most to the matrix, restricting our subsequent analysis to the first left singular vector (lsv). The first lsv represents a weighted average and distinguishes proteins by their averaged overall expression. The coefficients of the first lsv were sorted based on their magnitudes. In this analysis, coefficients were retained if their magnitudes were larger than a cutoff ≈0.002. The significance of the cutoff is that it provides a scale-independent way to determine the proteins that were enriched from the immunoprecipitation experiments while reducing the excess noise. Using this cutoff, 125 proteins were found corresponding to the most essential proteins in the dataset. More importantly, these 125 proteins contained all reported members of the SRCAP (15), hINO80 (16), and TRRAP/TIP60 (17) multiprotein complexes. Definition of Protein Complexes. A symmetric binary matrix was constructed based on reciprocal pull down of the baits. For two baits, a value of 1 was assigned if they copurify in both direction (i.e., if one protein is prey in the purification by using the second protein as a bait and vice versa) and 0 otherwise. Hierarchical clustering was then applied to the binary matrix. Based on the resulting matrix (Fig. 1 Assuming that the baits belonging to the same cluster should generally pull-down common proteins, we verified this by calculating a similarity value defined by the Jaccard index to each of the bait pairs. Given two sets of purifications A and B, na and nb count the number of proteins in individual purifications A and B, and ni is the number of proteins present in both purifications. The Jaccard index is defined as the ratio between the number of proteins present in both sets of purifications and the number of proteins present in either one:
Derivation of the Posterior Probabilities. Our goal was to compute a probability for each bait–prey interaction pair based on the NSAF (SI Text). To quantify the association preference between an affinity candidate protein i (i = 1,…, N) and a protein bait j (j = 1,…, M), we first estimated the conditional probability by:
P(j) is the likelihood that protein j participates in an association and is estimated by:
For a bait, l, j, and prey, i, the posterior probability P(j|i) defined by Bayes' rule:
Supporting Information
ACKNOWLEDGMENTS. We thank Arcady Mushegian, Matthias Wahl, and Timothy Doerr for valuable discussions during the preparation of this manuscript. Footnotes The authors declare no conflict of interest. This article is a PNAS Direct Submission. This article contains supporting information online at www.pnas.org/cgi/content/full/0706983105/DC1. References 1. Uetz P, Giot L, Cagney G, Mansfield TA, Judson RS, Knight JR, Lockshon D, Narayan V, Srinivasan M, Pochart P, et al. Nature. 2000;403:623–627. [PubMed] 2. Ito T, Chiba T, Ozawa R, Yoshida M, Hattori M, Sakaki Y. Proc Natl Acad Sci USA. 2001;98:4569–4574. [PubMed] 3. Rual JF, Venkatesan K, Hao T, Hirozane-Kishikawa T, Dricot A, Li N, Berriz GF, Gibbons FD, Dreze M, Ayivi-Guedehoussou N, et al. Nature. 2005;437:1173–1178. [PubMed] 4. Stelzl U, Worm U, Lalowski M, Haenig C, Brembeck FH, Goehler H, Stroedicke M, Zenkner M, Schoenherr A, Koeppen S, et al. Cell. 2005;122:957–968. [PubMed] 5. Krogan NJ, Cagney G, Yu H, Zhong G, Guo X, Ignatchenko A, Li J, Pu S, Datta N, Tikuisis AP, et al. Nature. 2006;440:637–643. [PubMed] 6. Gavin AC, Aloy P, Grandi P, Krause R, Boesche M, Marzioch M, Rau C, Jensen LJ, Bastuck S, Dumpelfeld B, et al. Nature. 2006;440:631–636. [PubMed] 7. Ewing RM, Chu P, Elisma F, Li H, Taylor P, Climie S, McBroom-Cerajewski L, Robinson MD, O'Connor L, Li M, et al. Mol Syst Biol. 2007;3:89. [PubMed] 8. Zhu X, Gerstein M, Snyder M. Genes Dev. 2007;21:1010–1024. [PubMed] 9. Collins SR, Kemmeren P, Zhao XC, Greenblatt JF, Spencer F, Holstege FC, Weissman JS, Krogan NJ. Mol Cell Proteomics. 2007;6:439–450. [PubMed] 10. Kobor MS, Venkatasubrahmanyam S, Meneghini MD, Gin JW, Jennings JL, Link AJ, Madhani HD, Rine J. PLoS Biol. 2004;2:E131. [PubMed] 11. Mizuguchi G, Shen X, Landry J, Wu WH, Sen S, Wu C. Science. 2004;303:343–348. [PubMed] 12. Shen X, Mizuguchi G, Hamiche A, Wu C. Nature. 2000;406:541–544. [PubMed] 13. Shen X, Ranallo R, Choi E, Wu C. Mol Cell. 2003;12:147–155. [PubMed] 14. Pu S, Vlasblom J, Emili A, Greenblatt J, Wodak SJ. Proteomics. 2007;7:944–960. [PubMed] 15. Ruhl DD, Jin J, Cai Y, Swanson S, Florens L, Washburn MP, Conaway RC, Conaway JW, Chrivia JC. Biochemistry. 2006;45:5671–5677. [PubMed] 16. Jin J, Cai Y, Yao T, Gottschalk AJ, Florens L, Swanson SK, Gutierrez JL, Coleman MK, Workman JL, Mushegian A, et al. J Biol Chem. 2005;280:41207–41212. [PubMed] 17. Cai Y, Jin J, Florens L, Swanson SK, Kusch T, Li B, Workman JL, Washburn MP, Conaway RC, Conaway JW. J Biol Chem. 2005;280:13665–13670. [PubMed] 18. Gstaiger M, Luke B, Hess D, Oakeley EJ, Wirbelauer C, Blondel M, Vigneron M, Peter M, Krek W. Science. 2003;302:1208–1212. [PubMed] 19. Blondeau F, Ritter B, Allaire PD, Wasiak S, Girard M, Hussain NK, Angers A, Legendre-Guillemin V, Roy L, Boismenu D, et al. Proc Natl Acad Sci USA. 2004;101:3833–3838. [PubMed] 20. Liu H, Sadygov RG, Yates JR., III Anal Chem. 2004;76:4193–4201. [PubMed] 21. Old WM, Meyer-Arendt K, Aveline-Wolf L, Pierce KG, Mendoza A, Sevinsky JR, Resing KA, Ahn NG. Mol Cell Proteomics. 2005;4:1487–1502. [PubMed] 22. Zybailov B, Coleman MK, Florens L, Washburn MP. Anal Chem. 2005;77:6218–6224. [PubMed] 23. Paoletti AC, Parmely TJ, Tomomori-Sato C, Sato S, Zhu D, Conaway RC, Weliky Conaway J, Florens L, Washburn MP. Proc Natl Acad Sci USA. 2006;103:18928–18933. [PubMed] 24. Zybailov B, Mosley AL, Sardiu ME, Coleman MK, Florens L, Washburn MP. J Proteome Res. 2006;5:2339–2347. [PubMed] 25. Alter O, Brown PO, Botstein D. Proc Natl Acad Sci USA. 2000;97:10101–10106. [PubMed] 26. Park J, Wood MA, Cole MD. Mol Cell Biol. 2002;22:1307–1316. [PubMed] 27. McAfee KJ, Duncan DT, Assink M, Link AJ. Mol Cell Proteomics. 2006;5:1497–1513. [PubMed] 28. Krogan NJ, Peng WT, Cagney G, Robinson MD, Haw R, Zhong G, Guo X, Zhang X, Canadien V, Richards DP, et al. Mol Cell. 2004;13:225–239. [PubMed] 29. Watkins NJ, Dickmanns A, Luhrmann R. Mol Cell Biol. 2002;22:8342–8352. [PubMed] 30. Asthana S, King OD, Gibbons FD, Roth FP. Genome Res. 2004;14:1170–1175. [PubMed] 31. Rhodes DR, Tomlins SA, Varambally S, Mahavisno V, Barrette T, Kalyana-Sundaram S, Ghosh D, Pandey A, Chinnaiyan AM. Nat Biotechnol. 2005;23:951–959. [PubMed] 32. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T. Genome Res. 2003;13:2498–2504. [PubMed] 33. Mishra GR, Suresh M, Kumaran K, Kannabiran N, Suresh S, Bala P, Shivakumar K, Anuradha N, Reddy R, Raghavan TM, et al. Nucleic Acids Res. 2006;34:D411–D414. [PubMed] 34. Wu WH, Alami S, Luk E, Wu CH, Sen S, Mizuguchi G, Wei D, Wu C. Nat Struct Mol Biol. 2005;12:1064–1071. [PubMed] 35. Cai Y, Jin J, Tomomori-Sato C, Sato S, Sorokina I, Parmely TJ, Conaway RC, Conaway JW. J Biol Chem. 2003;278:42733–42736. [PubMed] 36. Gavin AC, Bosche M, Krause R, Grandi P, Marzioch M, Bauer A, Schultz J, Rick JM, Michon AM, Cruciat CM, et al. Nature. 2002;415:141–147. [PubMed] 37. Gordon S, Akopyan G, Garban H, Bonavida B. Oncogene. 2006;25:1125–1142. [PubMed] 38. Florens L, Carozza MJ, Swanson SK, Fournier M, Coleman MK, Workman JL, Washburn MP. Methods. 2006;40:303–311. [PubMed] 39. Kuruvilla FG, Park PJ, Schreiber SL. Genome Biol. 2002;3:RESEARCH0011. [PubMed] 40. Fogolari F, Tessari S, Molinari H. Proteins. 2002;46:161–170. [PubMed] 41. Wall ME, Dyck PA, Brettin TS. Bioinformatics. 2001;17:566–568. [PubMed] 42. Slonim N, Atwal GS, Tkacik G, Bialek W. Proc Natl Acad Sci USA. 2005;102:18297–18302. [PubMed] |
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||||||||||||
Nature. 2000 Feb 10; 403(6770):623-7.
[Nature. 2000]Proc Natl Acad Sci U S A. 2001 Apr 10; 98(8):4569-74.
[Proc Natl Acad Sci U S A. 2001]Nature. 2005 Oct 20; 437(7062):1173-8.
[Nature. 2005]Cell. 2005 Sep 23; 122(6):957-68.
[Cell. 2005]Nature. 2006 Mar 30; 440(7084):637-43.
[Nature. 2006]PLoS Biol. 2004 May; 2(5):E131.
[PLoS Biol. 2004]Science. 2004 Jan 16; 303(5656):343-8.
[Science. 2004]Nature. 2000 Aug 3; 406(6795):541-4.
[Nature. 2000]Mol Cell. 2003 Jul; 12(1):147-55.
[Mol Cell. 2003]Proteomics. 2007 Mar; 7(6):944-60.
[Proteomics. 2007]Proc Natl Acad Sci U S A. 2004 Mar 16; 101(11):3833-8.
[Proc Natl Acad Sci U S A. 2004]Anal Chem. 2004 Jul 15; 76(14):4193-201.
[Anal Chem. 2004]Mol Cell Proteomics. 2005 Oct; 4(10):1487-502.
[Mol Cell Proteomics. 2005]Anal Chem. 2005 Oct 1; 77(19):6218-24.
[Anal Chem. 2005]Proc Natl Acad Sci U S A. 2006 Dec 12; 103(50):18928-33.
[Proc Natl Acad Sci U S A. 2006]Proc Natl Acad Sci U S A. 2000 Aug 29; 97(18):10101-6.
[Proc Natl Acad Sci U S A. 2000]Biochemistry. 2006 May 2; 45(17):5671-7.
[Biochemistry. 2006]J Biol Chem. 2005 Dec 16; 280(50):41207-12.
[J Biol Chem. 2005]J Biol Chem. 2005 Apr 8; 280(14):13665-70.
[J Biol Chem. 2005]J Biol Chem. 2005 Dec 16; 280(50):41207-12.
[J Biol Chem. 2005]Biochemistry. 2006 May 2; 45(17):5671-7.
[Biochemistry. 2006]J Biol Chem. 2005 Apr 8; 280(14):13665-70.
[J Biol Chem. 2005]Science. 2003 Nov 14; 302(5648):1208-12.
[Science. 2003]Nature. 2000 Feb 10; 403(6770):623-7.
[Nature. 2000]Biochemistry. 2006 May 2; 45(17):5671-7.
[Biochemistry. 2006]J Biol Chem. 2005 Dec 16; 280(50):41207-12.
[J Biol Chem. 2005]J Biol Chem. 2005 Apr 8; 280(14):13665-70.
[J Biol Chem. 2005]Science. 2003 Nov 14; 302(5648):1208-12.
[Science. 2003]Mol Cell Biol. 2002 Mar; 22(5):1307-16.
[Mol Cell Biol. 2002]Nature. 2006 Mar 30; 440(7084):631-6.
[Nature. 2006]Mol Cell Proteomics. 2006 Aug; 5(8):1497-513.
[Mol Cell Proteomics. 2006]Mol Cell. 2004 Jan 30; 13(2):225-39.
[Mol Cell. 2004]Mol Cell Biol. 2002 Dec; 22(23):8342-52.
[Mol Cell Biol. 2002]Genome Res. 2004 Jun; 14(6):1170-5.
[Genome Res. 2004]Nat Biotechnol. 2005 Aug; 23(8):951-9.
[Nat Biotechnol. 2005]Genome Res. 2003 Nov; 13(11):2498-504.
[Genome Res. 2003]Nucleic Acids Res. 2006 Jan 1; 34(Database issue):D411-4.
[Nucleic Acids Res. 2006]Nat Struct Mol Biol. 2005 Dec; 12(12):1064-71.
[Nat Struct Mol Biol. 2005]J Biol Chem. 2003 Oct 31; 278(44):42733-6.
[J Biol Chem. 2003]Nature. 2006 Mar 30; 440(7084):637-43.
[Nature. 2006]Nature. 2006 Mar 30; 440(7084):631-6.
[Nature. 2006]Nature. 2002 Jan 10; 415(6868):141-7.
[Nature. 2002]Nature. 2006 Mar 30; 440(7084):637-43.
[Nature. 2006]Nature. 2006 Mar 30; 440(7084):631-6.
[Nature. 2006]Oncogene. 2006 Feb 23; 25(8):1125-42.
[Oncogene. 2006]J Biol Chem. 2005 Dec 16; 280(50):41207-12.
[J Biol Chem. 2005]J Biol Chem. 2005 Apr 8; 280(14):13665-70.
[J Biol Chem. 2005]Biochemistry. 2006 May 2; 45(17):5671-7.
[Biochemistry. 2006]J Biol Chem. 2005 Apr 8; 280(14):13665-70.
[J Biol Chem. 2005]J Biol Chem. 2005 Dec 16; 280(50):41207-12.
[J Biol Chem. 2005]Methods. 2006 Dec; 40(4):303-11.
[Methods. 2006]Genome Biol. 2002; 3(3):RESEARCH0011.
[Genome Biol. 2002]Proc Natl Acad Sci U S A. 2000 Aug 29; 97(18):10101-6.
[Proc Natl Acad Sci U S A. 2000]Genome Biol. 2002; 3(3):RESEARCH0011.
[Genome Biol. 2002]Proteins. 2002 Feb 1; 46(2):161-70.
[Proteins. 2002]Bioinformatics. 2001 Jun; 17(6):566-8.
[Bioinformatics. 2001]Biochemistry. 2006 May 2; 45(17):5671-7.
[Biochemistry. 2006]Nature. 2006 Mar 30; 440(7084):637-43.
[Nature. 2006]Proc Natl Acad Sci U S A. 2005 Dec 20; 102(51):18297-302.
[Proc Natl Acad Sci U S A. 2005]